#ovarian-cancer

Diagnostic Histopathology of Tumors E-Book

Christopher D. M. Fletcher

Hacker & Moore's Essentials of Obstetrics and Gynecology E-Book

Neville F. Hacker, Joseph C. Gambone, Calvin J. Hobel

Clinical Gynecologic Oncology E-Book

Philip J. Disaia, William T. Creasman

Cytology E-Book

Barbara S. Ducatman, Edmund S. Cibas

Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat

Huang Yiping, Jiang Wei, Wang Yisheng, Zheng Yufang, Cong Qing, Xu Congjian, Xu

High efficacy of CpG-ODN, Cetuximab and Cisplatin combination for very advanced ovarian xenograft tumors

Sommariva Michele, Meini Alessandra, Cataldo Alessandra, Zaffaroni Nadia, Tagliabue Elda, Balsari, Balsari Andrea, De

Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study

Kunos Charles, Radivoyevitch Tomas, Abdul-Karim, Fanning James, Abulafia Ovadia, Bonebrake, Usha Lydia, Usha

HER2Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Broå¼Ek Izabela, Kardaå› Iwona, Ochman Karolina, Dä™Bniak Jaroså‚Aw, Stukan Maciej, Ratajska Magdalena, Morzuch Lucyna, Emerich Janusz, Limon, Limon Janusz

Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination

Watanabe Takafumi, Sugino Takashi, Nishiyama Hiroshi, Morimura Yutaka, Yamada Hidekazu, Goodison Steve, Fujimori, Fujimori Keiya, Hashimoto Toshihiro, Soeda Shu

The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study

Varughese Elizabeth, Kondalsamy-Chennakesavan Srinivas, Obermair, Obermair Andreas

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors

Edassery, Barua Animesh, Abramowicz, Bahr, Hellstrom Ingegerd, Luborsky, Yu Yi

Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer

Nodin Björn, Fridberg Marie, Uhlén Mathias, Jirström, Jirström Karin

Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics

Shetty Vivekananda, Hafner Julie, Shah Punit, Nickens Zacharie, Philip Ramila, Philip

Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples

Gallagher, Heffron, Laios Alexandros, O'Toole, Ffrench Brendan, Smyth, Elbaruni, Spillane, Sheils, O'Leary, Martin, Flavin

Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer

Butler Greg, Dowdy, Mariani Andrea, Knutson, Federspiel, Galanis Evanthia, Dietz, Peng, Peng Kah-Whye, Mader, Russell

BRCA1 4153delA founder mutation in Russian ovarian cancer patients

Krylova Nadezhda, Lobeiko, Sokolenko, Iyevleva, Rozanov, Mitiushkina, Gergova, Porhanova, Urmancheyeva, Maximov Sergey, Togo, Imyanitov

Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures

Miskimins, Miskimins W, Chan

Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel

Narendrula Rashmi, Guo Baoqing, Parissenti, Mccallum, Cull Stephanie, Lannér, Lannér Carita, Armstrong

Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers

Kim Ki, Jo Moo, Suh Dong, Yoon Man, Shin Dong, Lee Jeong, Choi, Choi Kyung

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium

Aust Stefanie, Bachmayr-Heyda Anna, Pateisky Petra, Tong Dan, Darb-Esfahani Silvia, Denkert Carsten, Chekerov Radoslav, Sehouli Jalid, Mahner Sven, Van, Vergote Ignace, Speiser Paul, Horvat Reinhard, Zeillinger Robert, Pils Dietmar

Identification of inhibitors of ovarian cancer stem-like cells by high-throughput screening

Mezencev Roman, Wang Lijuan, Mcdonald

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer

Wang Ning, Yao Qin, Wang Yankui, Dai Shuzhen, Yang Xingsheng, Yang, Hui Zhang

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests

Nobbenhuis, Bancroft Elizabeth, Moskovic Eleanor, Lennard Fiona, Pharoah Paul, Jacobs Ian, Ward Ann, Barton, Shepherd, Bridges, Gore Martin, Haracopos Chris, Shanley Susan, Ardern-Jones Audrey, Thomas Sarah, Eeles Ros, Ind

ß3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells

Tumbarello, Temple Jillian, Brenton

Selected aspects of genetic counselling for BRCA1mutation carriers

Gronwald

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

Goncharenko-Khaider Nadzeya, Matte Isabelle, Lane Denis, Rancourt Claudine, Piché, Piché Alain

MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells

Ponnusamy, Seshacharyulu Parthasarathy, Vaz Arokiapriyanka, Dey Parama, Batra

Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures

Levin, Panchabhai Sonali, Shen Li, Baggerly

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

Lee Heejeong, Park Chul, Deftereos Georgios, Morihara Janice, Stern, Swisher Elizabeth, Hawes, Kiviat, Feng Qinghua, Feng

Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1and BRCA2Genes Associated with Increased Risk of Breast Cancer in the Polish Population

Górski